Congratulations to the IDIGH Program PIs who have received grants to understand and fight COVID-19:

MI4 Emergency COVID—19 Research Funding (Round 1)

*IDIGH PIs in bold

  • Drs. Matthew Cheng, Erwin Schurr and Guillaume Bourque titled: Genomic biomarkers to predict outcome and treatment response in hospitalized COVID-19 patients
  • Drs. Jorg H. Fritz and Ciriaco A. Piccirillo titled: Defining the protective host immune response to SARS-CoV-2
  • Drs. Todd C. Lee, Emily G. McDonald and Matthew P. Cheng, titled: Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial (COVID19 PEP RCT – Canada)
  • Drs. Matthew P. Cheng, Leighanne O. Parkes, Todd C. Lee and Emily G. McDonald, titled: A Multi-centre, Adaptive, Randomized, Open-label, Controlled Clinical Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Patients in Canada (CATCO)

For more information on this grant and to view the full list of grant recipients, click here.

CIHR—Novel Coronavirus (COVID-19) Rapid Research Funding Opportunity

IDIGH Calendar

<<  <  June 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
  1  2  3  4  5  6  7
  8  911121314
15161718192021
22232425262728
2930     

Latest IDIGH Publications

  1. Del Corpo, O., Butler-Laporte, G., Sheppard, D. C., Cheng, M. P., McDonald, E. G. & Lee, T. C.
    (2020)
    .
    Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
    .
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  2. Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., Grivas, P., Painter, C. A., Peters, S., Thompson, M. A., Bakouny, Z., Batist, G., Bekaii-Saab, T., Bilen, M. A., Bouganim, N., Larroya, M. B., Castellano, D., Del Prete, S. A., Doroshow, D. B., Egan, P. C., Elkrief, A., Farmakiotis, D., Flora, D., Galsky, M. D., Glover, M. J., Griffiths, E. A., Gulati, A. P., Gupta, S., Hafez, N., Halfdanarson, T. R., Hawley, J. E., Hsu, E., Kasi, A., Khaki, A. R., Lemmon, C. A., Lewis, C., Logan, B., Masters, T., McKay, R. R., Mesa, R. A., Morgans, A. K., Mulcahy, M. F., Panagiotou, O. A., Peddi, P., Pennell, N. A., Reynolds, K., Rosen, L. R., Rosovsky, R., Salazar, M., Schmidt, A., Shah, S. A., Shaya, J. A., Steinharter, J., Stockerl-Goldstein, K. E., Subbiah, S., Vinh, D. C., Wehbe, F. H., Weissmann, L. B., Wu, J.-T., Wulff-Burchfield, E., Xie, Z., Yeh, A., Yu, P. P., Zhou, A. Y., Zubiri, L., Mishra, S., Lyman, G. H., Rini, B. I., Warner, J. L. & COVID-19 and Cancer Consortium.
    (2020)
    .
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
    .
    Lancet (London, England)
  3. Costiniuk, C. T. & Jenabian, M.-A.
    (2020)
    .
    Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    .
    Cytokine & growth factor reviews
  4. Perera, D., Golizeh, M. & Ndao, M.
    (2020)
    .
    A Procedure for Analyzing the Proteomic Proteomics Profile of Schistosoma mansoni Cercariae
    .
    Methods in molecular biology (Clifton, N.J.)
    ,
    vol
    .
    2151
    ,
    p
    .
    75-84
    .
  5. Mukherjee, M., Forero, D. F., Tran, S., Boulay, M.-E., Bertrand, M., Bhalla, A., Cherukat, J., Al-Hayyan, H., Ayoub, A., Revill, S. D., Javkar, T., Radford, K., Kjarsgaard, M., Huang, C., Dvorkin-Gheva, A., Ask, K., Olivenstein, R., Dendukuri, N., Lemiere, C., Boulet, L.-P., Martin, J. G. & Nair, P.
    (2020)
    .
    Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
    .
    The European respiratory journal
More publications